Researchers Use Radiomics to Predict Who Will Benefit from Chemotherapy (IMAGE)

Radiological Society of North America

Researchers Use Radiomics to Predict Who Will Benefit from Chemotherapy

Caption

Radiomic feature maps show differences between lesions in responders and lesions in nonresponders at pretreatment CT. There appears to be overexpression of radiomic features (A, peritumoral Gabor and, B, intratumoral Laws features) in the nonresponder lesion compared with the responder lesion. The distribution of the features shows significant differences between the two lesion categories; these differences are captured by the skewness and kurtosis statistics of the feature distribution.

Credit

Radiological Society of North America

Usage Restrictions

May use with credit.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.